Good vision relies on the integrity of the visual system, which involves the eye as well as the brain. Limited visual performance may follow from damage to either or both. Such damage also causes neural reorganization and/or degeneration, thereby influencing visual performance in ways that cannot be captured well by assessing eye or brain structure and function in isolation.
This Research Topic is dedicated to recent advances in the characterization, diagnostics, prognostics, and treatment of such neuro-ophthalmic disorders, with a particular focus on novel approaches toward measuring and improving visual functioning in daily life. Our aim is to collect papers addressing underacknowledged aspects of neuro-ophthalmic functioning, as well as possible influences of cognition, neural plasticity, stability, and degeneration in the face of neural or ocular disease.
Example topics include (but are not limited to):
- Advanced characterizations of neuro-ophthalmic functioning: E.g., novel methods based on neuroimaging, eye-tracking, adaptive optics imaging; characterizations of neural plasticity, stability, and degeneration; investigations into underacknowledged aspects of visual functioning such as temporal processing and oculomotor control; novel neuropsychological assessment of visual-attentional deficits; studies of neuro-ophthalmic functioning in diseases such as ischemic optic neuropathies, temporary compression of the optic nerves/chiasm/tracts, demyelinating diseases such as multiple sclerosis.
- Novel diagnostic and prognostic tools for neuro-ophthalmic disorders: E.g., new visual field perimetry approaches; novel measures of QoL/ADL and the role of cognitive enhancement for rehabilitation; tools based on neuroimaging, eye-tracking, virtual and augmented reality technologies; visual disorders as markers of neurological and neuropsychiatric diseases; markers of future clinical loss or of visual restorative potential.
- Advances in treatment of neuro-ophthalmic disorders: E.g., using visual prostheses, electrostimulation, optogenetics, sensory substitution, restitution training, attentional manipulations, multisensory integration, overcoming neural adaptation to optical abnormalities; approaches to address visual processing deficits after emergence from congenital blindness.
Krystel Huxlin is a co-inventor on US Patent No. 7,549,743, a visual restoration and evaluation technology, which includes both computerized visual psychophysical approaches and virtual reality.
The other Topic Editors declare no competing interests with regards to the Research Topic.
Good vision relies on the integrity of the visual system, which involves the eye as well as the brain. Limited visual performance may follow from damage to either or both. Such damage also causes neural reorganization and/or degeneration, thereby influencing visual performance in ways that cannot be captured well by assessing eye or brain structure and function in isolation.
This Research Topic is dedicated to recent advances in the characterization, diagnostics, prognostics, and treatment of such neuro-ophthalmic disorders, with a particular focus on novel approaches toward measuring and improving visual functioning in daily life. Our aim is to collect papers addressing underacknowledged aspects of neuro-ophthalmic functioning, as well as possible influences of cognition, neural plasticity, stability, and degeneration in the face of neural or ocular disease.
Example topics include (but are not limited to):
- Advanced characterizations of neuro-ophthalmic functioning: E.g., novel methods based on neuroimaging, eye-tracking, adaptive optics imaging; characterizations of neural plasticity, stability, and degeneration; investigations into underacknowledged aspects of visual functioning such as temporal processing and oculomotor control; novel neuropsychological assessment of visual-attentional deficits; studies of neuro-ophthalmic functioning in diseases such as ischemic optic neuropathies, temporary compression of the optic nerves/chiasm/tracts, demyelinating diseases such as multiple sclerosis.
- Novel diagnostic and prognostic tools for neuro-ophthalmic disorders: E.g., new visual field perimetry approaches; novel measures of QoL/ADL and the role of cognitive enhancement for rehabilitation; tools based on neuroimaging, eye-tracking, virtual and augmented reality technologies; visual disorders as markers of neurological and neuropsychiatric diseases; markers of future clinical loss or of visual restorative potential.
- Advances in treatment of neuro-ophthalmic disorders: E.g., using visual prostheses, electrostimulation, optogenetics, sensory substitution, restitution training, attentional manipulations, multisensory integration, overcoming neural adaptation to optical abnormalities; approaches to address visual processing deficits after emergence from congenital blindness.
Krystel Huxlin is a co-inventor on US Patent No. 7,549,743, a visual restoration and evaluation technology, which includes both computerized visual psychophysical approaches and virtual reality.
The other Topic Editors declare no competing interests with regards to the Research Topic.
